The suit claimed that Biogen paid millions of dollars to doctors in the form of speaker honoraria ... the abject failure of Alzheimer's drug and former blockbuster hope Aduhelm (aducanumab ...

In the first major deal at MIT’s ambitious overhaul of the old Volpe Center in Kendall Square, Cambridge drugmaker Biogen ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.

Biogen and Sangamo have begun a collaboration to develop gene regulation therapies for neurological diseases including Parkinson’s and Alzheimer’s in a collaboration worth more than $2.7 billion.

The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight ...

Some authors disclosed receiving honoraria or financial support from or serving as consultants, speakers, or advisory board members for several pharmaceutical companies. One author reported being ...

We've been blasting the best PC speakers all day and all night to find out if they've got what it takes to earn a place on our desks. Sure the best gaming headsets will give you a more intimate ...

Bluetooth speakers have been a major fixture in my life ever since I picked up the original Ultimate Ears Boom in college. I use them to listen to podcasts or my favorite playlists while I’m ...

Mar. 19, 2025 — An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a ...

After hours: March 21 at 7:27:47 PM EDT Loading Chart for BIIB ...